How Much Upside is Left in BioLife Solutions (BLFS)? Wall Street Analysts Think 41.72% - Nasdaq
6 hours ago • Google News
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and .
6 hours ago • Google News
4 days ago • Google News